Key result
Systemic corticosteroids reduce pericardial effusion in a case of pleuro-myopericarditis intolerant to NSAIDs and colchicine.
Why the study?
Evidence supporting first-line NSAIDs and colchicine for acute pericarditis derives largely from younger, stable populations, leaving frail older patients underrepresented and highlighting a gap in real-world applicability.
Case Report (n=1)
No
Guideline-directed first-line therapy for acute pericarditis (NSAIDs and colchicine) may be poorly tolerated in frail older adults, highlighting the need for individualized strategies such as corticosteroids.
Answers are grounded in this paper and cite their sources.
May warrant caution applying NSAID/colchicine guidelines to frail elderly pericarditis patients; leaves open need for age-specific trials.
Introduction Current ESC guidelines recommend NSAIDs and colchicine as first-line therapy for acute pericarditis. However, supporting evidence is largely derived from younger and clinically stable populations, with frail older patients underrepresented, highlighting a gap between guideline recommendations and real-world applicability. Case presentation We report the case of an 87-year-old frail man with multiple comorbidities who developed pleuro-myopericarditis with moderate-to-severe pericardial effusion. First-line therapy with ibuprofen and colchicine was initiated but discontinued early due to severe gastrointestinal intolerance and worsening renal function. Pericardiocentesis was considered; however, according to current guideline recommendations, it is primarily indicated in the presence of cardiac tamponade or for selected diagnostic purposes. In this case, the absence of hemodynamic compromise and the high procedural risk related to frailty led to conservative management. A corticosteroid-based regimen was therefore initiated, resulting in clinical improvement and gradual reduction of pericardial effusion. Discussion This case highlights the limitations of guideline-directed therapy in frail elderly patients, in whom comorbidities, renal dysfunction, and polypharmacy frequently limit the tolerability of NSAIDs and colchicine. It underscores the gap between guideline recommendations and real-world clinical applicability, emphasizing the need for individualized therapeutic strategies. Conclusion Management of acute pericarditis in frail older adults should be individualized, integrating guideline recommendations with geriatric assessment and clinical judgment. Optimal treatment may differ from guideline-based strategies when patient-specific risks outweigh expected benefits. This case underscores the urgent need for evidence specifically addressing this growing and vulnerable population.
No takes yet. Share an insight, caveat, or question.
Artuso et al. (2026) conducted a case report in Pleuro-myopericarditis (n=1). Ibuprofen and colchicine followed by prednisone was evaluated on Clinical improvement and reduction of pericardial effusion. In an 87-year-old frail man with pleuro-myopericarditis, guideline-directed therapy with NSAIDs and colchicine was poorly tolerated, whereas low-dose corticosteroids provided symptomatic relief.
Synapse has enriched 10 related papers. Consider them for comparative context: